Payment overview · 2025
General Payments
$26.06
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mark Alan Stutzman, DO
Allopathic & Osteopathic Physicians|Family Medicine · WOOSTER, OH · NPI 1659536761
Verified facts
What the public records show
CMS Open Payments records show Mark Alan Stutzman, DO received $26.06 in general payments during 2025 across 1 reported records.
Seqirus USA Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $26.06 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $26.06 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Fluad Normalized: fluad |
Biological | Seqirus USA Inc | $26.06 | 1 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $26.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 504 | 126 |
| Atorvastatin Calcium | Atorvastatin Calcium | 449 | 114 |
| Levothyroxine Sodium | Levothyroxine Sodium | 426 | 95 |
| Omeprazole | Omeprazole | 377 | 86 |
| Lisinopril | Lisinopril | 374 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 311 | 78 |
| Gabapentin | Gabapentin | 292 | 67 |
| Metformin Hcl | Metformin Hcl | 285 | 64 |
| Losartan Potassium | Losartan Potassium | 257 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 229 | 57 |
| Tramadol Hcl | Tramadol Hcl | 209 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 200 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 192 | 45 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 182 | 24 |
| Hydrochlorothiazide | Hydrochlorothiazide | 177 | 50 |
| Citalopram Hbr | Citalopram Hydrobromide | 162 | 42 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 160 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 157 | 28 |
| Potassium Chloride | Potassium Chloride | 156 | 42 |
| Trazodone Hcl | Trazodone Hcl | 152 | 25 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 150 | 39 |
| Prednisone | Prednisone | 144 | 80 |
| Sertraline Hcl | Sertraline Hcl | 144 | 29 |
| Alprazolam | Alprazolam | 141 | 22 |
| Meloxicam | Meloxicam | 139 | 38 |
| Lorazepam | Lorazepam | 132 | 32 |
| Furosemide | Furosemide | 131 | 37 |
| Glipizide | Glipizide | 124 | 31 |
| Allopurinol | Allopurinol | 123 | 27 |
| Bupropion Xl | Bupropion Hcl | 118 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 117 | 31 |
| Simvastatin | Simvastatin | 117 | 31 |
| Buspirone Hcl | Buspirone Hcl | 116 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 116 | 28 |
| Zolpidem Tartrate | Zolpidem Tartrate | 108 | 17 |
| Alendronate Sodium | Alendronate Sodium | 107 | 20 |
| Oxycodone Hcl | Oxycodone Hcl | 107 | 13 |
| Atenolol | Atenolol | 106 | 23 |
| Carvedilol | Carvedilol | 99 | 25 |
| Eliquis | Apixaban | 97 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 92 | 21 |
| Donepezil Hcl | Donepezil Hcl | 90 | 22 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 90 | 19 |
| Warfarin Sodium | Warfarin Sodium | 88 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 85 | 13 |
| Famotidine | Famotidine | 84 | 22 |
| Glimepiride | Glimepiride | 83 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 83 | 16 |
| Ozempic | Semaglutide | 82 | 15 |
| Pregabalin | Pregabalin | 82 | 20 |
| Diazepam | Diazepam | 75 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 75 | 53 |
| Januvia | Sitagliptin Phosphate | 74 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | 20 |
| Trulicity | Dulaglutide | 72 | suppressed |
| Celecoxib | Celecoxib | 70 | 14 |
| Jardiance | Empagliflozin | 70 | 18 |
| Spironolactone | Spironolactone | 69 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 68 | 43 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 63 | 49 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 62 | suppressed |
| Ramipril | Ramipril | 60 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 58 | 38 |
| Xarelto | Rivaroxaban | 58 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 57 | 13 |
| Fluticasone Propionate | Fluticasone Propionate | 57 | 18 |
| Sumatriptan Succinate | Sumatriptan Succinate | 57 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 56 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 53 | 20 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 13 |
| Ezetimibe | Ezetimibe | 52 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 51 | 31 |
| Clonazepam | Clonazepam | 50 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 50 | 12 |
| Lansoprazole | Lansoprazole | 47 | suppressed |
| Synthroid | Levothyroxine Sodium | 47 | 13 |
| Memantine Hcl | Memantine Hcl | 46 | 13 |
| Ondansetron Odt | Ondansetron | 45 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 44 | suppressed |
| Azithromycin | Azithromycin | 43 | 42 |
| Lovastatin | Lovastatin | 43 | suppressed |
| Finasteride | Finasteride | 39 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 39 | suppressed |
| Klor-Con M20 | Potassium Chloride | 38 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 38 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 36 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Fluconazole | Fluconazole | 34 | 16 |
| Meclizine Hcl | Meclizine Hcl | 33 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 33 | 15 |
| Farxiga | Dapagliflozin Propanediol | 32 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 32 | 13 |
| Metolazone | Metolazone | 31 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 31 | suppressed |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 30 | suppressed |
| Glipizide Er | Glipizide | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Temazepam | Temazepam | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 27 | suppressed |
| Ibuprofen | Ibuprofen | 27 | suppressed |
| Cefdinir | Cefdinir | 26 | 17 |
| Propranolol Hcl Er | Propranolol Hcl | 26 | suppressed |
| Trokendi Xr | Topiramate | 26 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 25 | 17 |
| Nitroglycerin | Nitroglycerin | 25 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Cilostazol | Cilostazol | 22 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 22 | suppressed |
| Myrbetriq | Mirabegron | 22 | suppressed |
| Mirtazapine | Mirtazapine | 21 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 20 | suppressed |
| Cephalexin | Cephalexin | 20 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 20 | suppressed |
| Lactulose | Lactulose | 20 | suppressed |
| Mounjaro | Tirzepatide | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Zaleplon | Zaleplon | 20 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Levofloxacin | Levofloxacin | 19 | 12 |
| Olanzapine | Olanzapine | 19 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 19 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 19 | suppressed |
| Desonide | Desonide | 18 | suppressed |
| Naproxen | Naproxen | 18 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 16 |
| Primidone | Primidone | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Topiramate | Topiramate | 16 | suppressed |
| Acyclovir | Acyclovir | 15 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 11 |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 15 | suppressed |
| Nifedipine Er | Nifedipine | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Phenobarbital | Phenobarbital | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Creon | Lipase/Protease/Amylase | 13 | suppressed |
| Dexamethasone | Dexamethasone | 13 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Sulfasalazine | Sulfasalazine | 13 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 12 | suppressed |
| Hydrocortisone Valerate | Hydrocortisone Valerate | 12 | suppressed |
| Nyamyc | Nystatin | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Repaglinide | Repaglinide | 11 | suppressed |
| Risperidone | Risperidone | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Unifine Pentips | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $26.06 · 1 records | Seqirus USA Inc | Fluad, Flucelvax | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error